Evidence map›Paper›PMID 36985396›Full record

ArticleMolecules (Basel, Switzerland)2023

Solubility Determination and Comprehensive Analysis of the New Heat-Resistant Energetic Material TNBP.

Luoluo Wang, Minchang Wang, Ying Kang, Yong Zhu, Hai Chang, Ning Liu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luoluo WangXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Minchang WangXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Ying KangXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Yong ZhuXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Hai ChangXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Ning LiuXi'an Modern Chemistry Research Institute, Xi'an 710065, China.ORCID 0000-0002-5113-2658

Funding

National Natural Science Foundation of China No.22175139
6 · The paper itself

Abstract

To improve the crystal quality of 4,8-bis(2,4,6-trinitrophenyl)difurazolo [3,4-b:3',4'-e] pyrazine (TNBP), the solubility of TNBP in organic solvents (six pure and four mixed solvents) was determined by the laser monitoring technique from 293.15 to 353.15 K. The results showed that the solubility was positively correlated with the increase in the experimental temperature and the main solvent content, except for the co-solvent phenomenon in the DMSO + ethyl acetate solvent mixture. To explain the dissolution behavior of TNBP, the KAT-SER model was analyzed for pure solvent systems, and it was found that hydrogen bonding alkalinity and self-cohesiveness were the main influencing factors. The free energy of solvation and radial distribution function of TNBP in mixed solvents were also obtained by molecular dynamics simulation, and the effect of solute-solvent and solvent-solvent interactions on the solubility trend was analyzed. The experimental data were correlated using three empirical equations (van't Hoff equation, modified Apelblat equation, and λh equation), and the deviation analysis showed the good applicability of the modified Apelblat model. Furthermore, the dissolution of TNBP was heat-absorbing and not spontaneous, according to the thermodynamic characteristics estimated by the van't Hoff equation.

Indexed as

4,8-bis(2,4,6-trinitrophenyl)difurazolo [3,4-b:3′,4′-e]pyrazinedissolution behaviorsolubilitythermodynamic properties

Identifiers

PMID36985396
PMCPMC10054621
OpenAlexW4323362874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.